Search
for
Sort by
Research 841–870 of 1000+
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Dermatosis associated with menopause
- Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache
- Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection
- RASopathic Skin Eruptions during Vemurafenib Therapy
- The dark art of light measurement: accurate radiometry for low-level light therapy
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Overexpression of mIGF-1 in Keratinocytes Improves Wound Healing and Accelerates Hair Follicle Formation and Cycling in Mice
- Extra-Intestinal Manifestation of Celiac Disease in Children
- Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies
- Female pattern alopecia: current perspectives
- Glucocorticoids Influencing Wnt/β-Catenin Pathway; Multiple Sites, Heterogeneous Effects
- Direct Vasodilators and Sympatholytic Agents
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Trichotillomania in Children
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Alopecia and Associated Toxic Agents: A Systematic Review
- Where Have the Periods Gone? The Evaluation and Management of Functional Hypothalamic Amenorrhea
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
- Menopausal Acne – Challenges And Solutions
- Tissue-Selective Regulation of Androgen-Responsive Genes
- Hormone Therapy in the Era of the COVID-19 Pandemic: A Review
- Female pattern hair loss—An update
- Female pattern hair loss
- Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery
- Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues
- Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Alopecia areata following COVID-19 vaccine: a systematic review
- Chikungunya virus infection in the skin: histopathology and cutaneous immunological response